| Literature DB >> 26487680 |
Tiffany Fleet1, Bin Zhang2, Fumin Lin2, Bokai Zhu2, Subhamoy Dasgupta2, Erin Stashi2, Bryan Tackett3, Sundararajah Thevananther4, Kimal I Rajapakshe2, Naomi Gonzales2, Adam Dean2, Jianqiang Mao2, Nikolai Timchenko5, Anna Malovannaya6, Jun Qin6, Cristian Coarfa2, Francesco DeMayo7, Clifford C Dacso8, Charles E Foulds2, Bert W O'Malley9, Brian York10.
Abstract
Despite extensive efforts to understand the monogenic contributions to perturbed glucose homeostasis, the complexity of genetic events that fractionally contribute to the spectrum of this pathology remain poorly understood. Proper maintenance of glucose homeostasis is the central feature of a constellation of comorbidities that define the metabolic syndrome. The ability of the liver to balance carbohydrate uptake and release during the feeding-to-fasting transition is essential to the regulation of peripheral glucose availability. The liver coordinates the expression of gene programs that control glucose absorption, storage, and secretion. Herein, we demonstrate that Steroid Receptor Coactivator 2 (SRC-2) orchestrates a hierarchy of nutritionally responsive transcriptional complexes to precisely modulate plasma glucose availability. Using DNA pull-down technology coupled with mass spectrometry, we have identified SRC-2 as an indispensable integrator of transcriptional complexes that control the rate-limiting steps of hepatic glucose release and accretion. Collectively, these findings position SRC-2 as a major regulator of polygenic inputs to metabolic gene regulation and perhaps identify a previously unappreciated model that helps to explain the clinical spectrum of glucose dysregulation.Entities:
Keywords: SRC-2; Steroid Receptor Coactivator 2; glucokinase; glucose homeostasis; polygenic disease
Mesh:
Substances:
Year: 2015 PMID: 26487680 PMCID: PMC4640775 DOI: 10.1073/pnas.1519073112
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205